Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes

Clinical trial NCT00380653 · COMPLETED

Trial details

NCT number: NCT00380653
Sponsor: Cyclacel Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemias Myelodysplastic Syndromes

Start date: 2006-01-01
Primary completion: 2008-11-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.